Nav1.8
Nav1.8, also known as sodium channel, voltage-gated, type X, alpha subunit (SCN10A), is a voltage-gated sodium channel that is primarily expressed in peripheral neurons. It plays a crucial role in the generation and conduction of action potentials in nociceptive neurons, which are responsible for the sensation of pain.
Structure
Nav1.8 is composed of an alpha subunit that forms the pore of the channel. The alpha subunit is a large transmembrane protein that consists of four homologous domains (I-IV), each containing six transmembrane segments (S1-S6). The S4 segment acts as the voltage sensor, while the S5 and S6 segments form the pore through which sodium ions pass. The intracellular loops between the domains are important for channel gating and modulation.
Function
Nav1.8 is unique among sodium channels due to its resistance to tetrodotoxin (TTX), a potent sodium channel blocker. This property allows Nav1.8 to continue functioning in conditions where other sodium channels are inhibited. Nav1.8 is activated at more depolarized membrane potentials compared to other sodium channels, which makes it particularly important in the transmission of pain signals under pathological conditions.
Expression
Nav1.8 is predominantly expressed in small-diameter dorsal root ganglion (DRG) neurons and trigeminal ganglion neurons. These neurons are involved in the transmission of nociceptive information from the periphery to the central nervous system. The expression of Nav1.8 can be upregulated in response to nerve injury or inflammation, contributing to chronic pain states.
Clinical Significance
Mutations in the SCN10A gene, which encodes the Nav1.8 channel, have been associated with various pain disorders. Gain-of-function mutations can lead to increased pain sensitivity, while loss-of-function mutations may result in reduced pain perception. Nav1.8 is a target for the development of new analgesic drugs aimed at treating chronic pain conditions without affecting normal sensory functions.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD